What are symptoms of uterine hyperstimulation that warranted stopping the medication?

Case Reports

. 1985 Sep;66(3 Suppl):16S-18S.

• PMID: 2862618

Case Reports

Use of tocolytic drugs to reverse oxytocin-induced uterine hypertonus and fetal distress

J Lipshitz et al. Obstet Gynecol. 1985 Sep.

Abstract

The use of oxytocin in labor has the inherent danger of producing uterine hyperstimulation with resultant fetal distress. When produced by gradual titration of intravenous oxytocin, discontinuation of the medication is usually sufficient to reverse the process. However, the rapid administration of a large intravenous dose of oxytocin, as occurred in this patient, may result in hypertonic uterine contractions and fetal distress unresponsive to traditional measures. The rationale for using a tocolytic drug to reverse the uterine hypertonus, produce intrauterine fetal resuscitation, and prevent cesarean section is discussed in this report.

Similar articles

• Methylergonovine-induced hypertonus in term pregnancy. A case report.

  Moise KJ Jr, Carpenter RJ Jr. Moise KJ Jr, et al. J Reprod Med. 1988 Sep;33(9):771-3. J Reprod Med. 1988. PMID: 3172085

• Fetal resuscitation with ritodrine during maternal seizures in labor. A case report.

  Weissman A, Zimmer EZ. Weissman A, et al. J Reprod Med. 1988 Aug;33(8):731-2. J Reprod Med. 1988. PMID: 3139876

• [Indications and management of tocolytic treatment].

  Matsuura S. Matsuura S. Nihon Sanka Fujinka Gakkai Zasshi. 1985 Jan;37(1):157-62. Nihon Sanka Fujinka Gakkai Zasshi. 1985. PMID: 2857755 Japanese. No abstract available.

• Acute tocolysis for uterine activity reduction in term labor: a review.

  de Heus R, Mulder EJ, Derks JB, Visser GH. de Heus R, et al. Obstet Gynecol Surv. 2008 Jun;63(6):383-8; quiz 405. doi: 10.1097/OGX.0b013e31816ff75b. Obstet Gynecol Surv. 2008. PMID: 18492294 Review.

• [Abnormal fetal heart rate patterns associated with different labour managements and intrauterine resuscitation techniques].

  Verspyck E, Sentilhes L. Verspyck E, et al. J Gynecol Obstet Biol Reprod (Paris). 2008 Feb;37 Suppl 1:S56-64. doi: 10.1016/j.jgyn.2007.11.011. Epub 2008 Jan 9. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 18187267 Review. French.

Cited by

• Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species.

  Muttenthaler M, Andersson Å, Vetter I, Menon R, Busnelli M, Ragnarsson L, Bergmayr C, Arrowsmith S, Deuis JR, Chiu HS, Palpant NJ, O'Brien M, Smith TJ, Wray S, Neumann ID, Gruber CW, Lewis RJ, Alewood PF. Muttenthaler M, et al. Sci Signal. 2017 Dec 5;10(508):eaan3398. doi: 10.1126/scisignal.aan3398. Sci Signal. 2017. PMID: 29208680 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

A nurse is administering oxytocin to a client in labor. What are symptoms of uterine hyperstimulationthat would cause the nurse to discontinue this medication?

Get answer to your question and much more

A client at 34-weeks of gestation presents to Labor and Delivery complaining of a sudden onset ofintense abdominal pain and vaginal bleeding. An ultrasound reveals a partial abruptio placentae.1) Listthree (3) risk factors for this condition and 2) list three (3) priority nursing interventions.

Get answer to your question and much more

A nurse is caring for a client with placenta previa. What interventions should be completed for thisclient?

Get answer to your question and much more

What are symptoms of uterine hyperstimulation?

What are symptoms of uterine hyperstimulation that warranted stopping oxytocin?

How do you stop uterine hyperstimulation?

What problems can result from uterine hyperstimulation?